Current preclinical in vivo models of ALS make use of transgenic mice overexpressing some of the most common gene mutations associated with ALS, typically SOD1, TDP-43, FUS, or C9ORF72. Here, C9orf72 is linked to amyotrophic lateral sclerosis.